Compare Prudential Financial Inc (PRU) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential Financial Inc vs GeneDx Holdings Corp — how do they compare? Prudential Financial Inc trades at $117.62 (market cap $41.19B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Prudential Financial Inc is far larger — about 16.1× GeneDx Holdings Corp's market cap, and Prudential Financial Inc pays a 4.69% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| PRU | WGS | |
|---|---|---|
Market Cap | $41.19B | $2.56B |
Sector | Financials | Technology |
52-Week High | $125.13 | $167.51 |
52-Week Low | $92.00 | $34.51 |
Enterprise Value | $69.96B | $2.60B |
Dividend Yield | 4.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Prudential Financial (PRU) trades at $119.38, down 2.16% today, with a neutral technical signal and bearish moving averages. The stock shows attractive valuation metrics with a P/E of 10.82 and P/S of 0.64, while recent earnings beat expectations in Q1 and Q2 2026. Revenue for 2025 was $60.97B with net income of $3.58B, and the company maintains a solid dividend of $1.40 per share. Recent news highlights participation in investor conferences and new product launches.
The outlook for PRU is mixed; fundamentals are strong with improving profitability and low valuation, but technical indicators and analyst consensus suggest caution. Risks include volatile cash flows and high debt levels. Wall Street sentiment is neutral with a consensus price target of $113.20, below the current price, indicating limited near-term upside potential.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
